Influence of genetic variants and post transcriptional factors on imatinib transporters as determinants of the pharmacological response
Introduction – Although imatinib (IM) is a recognized gold standard in chronic myeloid leukemia (CML) therapy, resistance has emerged in a significant proportion of patients. Aim – The aim of this study was: (1) to investigate the role of genetic variants in genes encoding for IM transporters, as...
Main Author: | |
---|---|
Other Authors: | |
Format: | Doctoral Thesis |
Language: | en |
Published: |
Alma Mater Studiorum - Università di Bologna
2011
|
Subjects: | |
Online Access: | http://amsdottorato.unibo.it/3830/ |